NanoViricides
NNVC
#10132
Rank
NZ$38.31 M
Marketcap
NZ$2.13
Share price
0.82%
Change (1 day)
-14.22%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of June 2025 : NZ$15.27 Million

According to NanoViricides's latest financial reports the company's total assets are NZ$15.27 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30NZ$21.02 M-23.7%
2023-06-30NZ$27.55 M-26.82%
2022-06-30NZ$37.65 M-12.95%
2021-06-30NZ$43.25 M16.68%
2020-06-30NZ$37.07 M85.32%
2019-06-30NZ$20 M-26.96%
2018-06-30NZ$27.38 M-25.75%
2017-06-30NZ$36.88 M-28.15%
2016-06-30NZ$51.33 M-21.15%
2015-06-30NZ$65.1 M30.07%
2014-06-30NZ$50.05 M136.04%
2013-06-30NZ$21.2 M8.88%
2012-06-30NZ$19.47 M49.97%
2011-06-30NZ$12.98 M-0.1%
2010-06-30NZ$13 M177.7%
2009-06-30NZ$4.68 M142.56%
2008-06-30NZ$1.92 M9.88%
2007-06-30NZ$1.75 M-61.03%
2006-06-30NZ$4.5 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
NZ$0.77 B 4,959.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.04 B 13,271.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$101.32 B 663,232.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.71 B 1,097,906.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$224.24 B 1,467,996.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$142.73 B 934,392.89%๐Ÿ‡ฌ๐Ÿ‡ง UK